Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GoHealth (GOCO) EPS (Weighted Average and Diluted) (2020 - 2025)

GoHealth (GOCO) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with -$1.03 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 141.53% to -$1.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$18.45 through Dec 2025, down 2206.25% year-over-year, with the annual reading at -$20.17 for FY2025, 2956.06% down from the prior year.
  • EPS (Weighted Average and Diluted) hit -$1.03 in Q4 2025 for GoHealth, up from -$11.8 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.48 in Q4 2024 to a low of -$26.47 in Q4 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$3.54 across 5 years, with a median of -$1.43 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 8600.0% in 2022 and later surged 1753.33% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$26.47 in 2021, then skyrocketed by 72.87% to -$7.18 in 2022, then soared by 97.91% to -$0.15 in 2023, then soared by 1753.33% to $2.48 in 2024, then plummeted by 141.53% to -$1.03 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for GOCO at -$1.03 in Q4 2025, -$11.8 in Q3 2025, and -$5.1 in Q2 2025.